GLP-1 TV · Clinician · views checked Oct 2026
Ozempic & Mounjaro: Same Shot. Opposite Results.
Our summary
A clinician (MD) explains how Ozempic works and what the evidence says, mentioning 2.4 mg. Side effects mentioned: nausea, constipation, fatigue, hair loss and heartburn or reflux. Also covers food, protein and eating, food noise and cravings and mood and mental health.
General education as published by the channel. Not medical advice, and not an endorsement.
Key moments
From the creator's own chapters. Tap one to play from there.
- 0:00 The Paradox: Same Drug, Opposite Outcomes
- 2:21 Weight Loss ≠ Metabolic Repair (Critical Concept)
- 4:50 How GLP-1s Actually Work (Beyond Appetite)
- 14:21 The 3-Dial Framework: Who Thrives vs Who Struggles
- 16:33 Thrive Phenotype A: High Appetite Drive + Insulin Resistance
- 18:12 Thrive Phenotype B: Inflammation-Driven Weight
- 19:02 Thrive Phenotype C: Cardiometabolic High Risk
- 20:17 Deterioration Phenotype 1: Low Reserve/Frailty Risk
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Ozempic, Mounjaro, semaglutide and tirzepatide
- Doses mentioned
- 2.4 mg
- Side effects mentioned
- nausea, constipation, fatigue, hair loss, heartburn or reflux, bloating, muscle loss, low appetite, gallbladder and pancreatitis
- Who is speaking
- Clinician, MD (Dr. Amin Hedayat)
In their words
"It's like the mental food noise finally goes down."
"But it's also why nausea happens."
Find more like it
Side effectsDose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsMood and mental healthExercise and strengthStopping and maintenanceHow it worksThe trials
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.